SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-20-000084
Filing Date
2020-11-19
Accepted
2020-11-19 17:27:56
Documents
16
Period of Report
2020-11-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20201113.htm   iXBRL 8-K 47231
2 EX-10.1 ex101patrickconsulting.htm EX-10.1 65018
3 EX-10.2 ex102schwabeconsulting.htm EX-10.2 59901
  Complete submission text file 0001356576-20-000084.txt   347270

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20201113.xsd EX-101.SCH 2436
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20201113_cal.xml EX-101.CAL 722
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20201113_def.xml EX-101.DEF 1659
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20201113_lab.xml EX-101.LAB 24274
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20201113_pre.xml EX-101.PRE 12658
9 EXTRACTED XBRL INSTANCE DOCUMENT supn-20201113_htm.xml XML 10780
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 201329711
SIC: 2834 Pharmaceutical Preparations